Labeler
Sandoz Inc NDC Codes
Sandoz Inc lists 440 finished drug products in the FDA NDC Directory under NDC labeler codes 0781, 61314.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Dexmethylphenidate Hydrochloride Extended-Release, Lisdexamfetamine dimesylate, Enoxaparin Sodium Injection,USP, Hyrimoz, Pomalidomide, Adalimumab, Bumetanide, Sitagliptin Phosphate, Iron Sucrose, Pyzchiva, Cyclophosphamide, Pirfenidone, Pemetrexed, Lidocaine Hydrochloride, Sugammadex
- Active ingredients
- Dexmethylphenidate hydrochloride, Adalimumab, Lisdexamfetamine dimesylate, Enoxaparin sodium, Sitagliptin phosphate, Pomalidomide, Bumetanide, Iron sucrose, Ustekinumab, Cyclophosphamide, Pirfenidone, Pemetrexed disodium
- NDC labeler codes
- 0781, 61314
- Strengths (from the 100 most recently listed products)
- Sitagliptin phosphate 50 mg/1; Adalimumab 10 mg/.1mL; Adalimumab 80 mg/.8mL; Adalimumab 20 mg/.2mL; Fulvestrant 50 mg/mL; Adalimumab 40 mg/.4mL; Pirfenidone 267 mg/1; Aflibercept 2 mg/.05mL; Lidocaine hydrochloride 10 mg/mL; Lidocaine hydrochloride 20 mg/mL; Dexmethylphenidate hydrochloride 25 mg/1; Dexmethylphenidate hydrochloride 30 mg/1; Dexmethylphenidate hydrochloride 35 mg/1; Dexmethylphenidate hydrochloride 40 mg/1; Bumetanide .5 mg/1; Bumetanide 1 mg/1; Bumetanide 2 mg/1; Dexmethylphenidate hydrochloride 15 mg/1; Dexmethylphenidate hydrochloride 5 mg/1; Dexmethylphenidate hydrochloride 10 mg/1
- Dosage forms
- Injection, Solution, Capsule, Tablet, Film coated, Injection, Capsule, Extended release, Tablet, Injection, Solution, Concentrate, Solution/ drops, Kit, Injection, Powder, Lyophilized, For solution, Concentrate, Suspension/ drops, Injection, Powder, For solution, Injection, Powder, Lyophilized, For suspension, Aerosol, Metered
- Routes
- Oral, Intravenous, Subcutaneous, Intravitreal, Ophthalmic, Epidural, Infiltration, Intracaudal, Perineural, Intramuscular, Parenteral, Respiratory (Inhalation)
- Drug classes (FDA established)
- Central Nervous System Stimulant, Tumor Necrosis Factor Blocker, Low Molecular Weight Heparin, Parenteral Iron Replacement, Dipeptidyl Peptidase 4 Inhibitor, Thalidomide Analog, Phosphate Binder, Vascular Endothelial Growth Factor Inhibitor, Loop Diuretic, Interleukin-12 Antagonist, Interleukin-23 Antagonist, Pyridone, Folate Analog Metabolic Inhibitor, Amide Local Anesthetic, Antiarrhythmic, Aminosalicylate, Biguanide, Sodium-Glucose Cotransporter 2 Inhibitor, Kinase Inhibitor, Microtubule Inhibitor, Serotonin-4 Receptor Agonist, RANK Ligand Inhibitor, alpha-Adrenergic Agonist, Estrogen Receptor Antagonist, Phenothiazine, Macrolide Antibacterial, Corticosteroid, Purine Antimetabolite, Proton Pump Inhibitor, Integrin Receptor Antagonist, Endothelin Receptor Antagonist, Barbiturate, Methylxanthine, Nonsteroidal Anti-inflammatory Drug, Platelet Aggregation Inhibitor, Nucleoside Metabolic Inhibitor, Prostaglandin Analog, beta-Adrenergic Blocker, Penicillin-class Antibacterial, beta Lactamase Inhibitor, beta2-Adrenergic Agonist
- HCPCS / J-code
- J0178 — Injection, aflibercept, 1 mg, J1756 — Injection, iron sucrose, 1 mg, J0897 — Injection, denosumab, 1 mg, J0135 — Injection, adalimumab, 20 mg, J3357 — Injection, ustekinumab, for subcutaneous injection, 1 mg, J2778 — Injection, ranibizumab, 0.1 mg
- Package NDCs
- 141 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Armodafinil | Armodafinil 250 mg/1 | TabletOral | 0781-8053 | 00781-8053-31 | — |
| Armodafinil | Armodafinil 50 mg/1 | TabletOral | 0781-8029 | 00781-8029-31 | — |
| Armodafinil | Armodafinil 150 mg/1 | TabletOral | 0781-8037 | 00781-8037-31 | — |
| Armodafinil | Armodafinil 200 mg/1 | TabletOral | 0781-8045 | 00781-8045-31 | — |
| Drospirenone/Ethinyl Estradiol/Levomefolate Calcium and Levomefolate Calcium | — | Kit | 0781-4075 | 00781-4075-15 | — |
| Arranonnelarabine | Nelarabine 5 mg/mL | InjectionIntravenous | 66758-165 | 66758-0165-94 | — |
| Gatifloxacin | Gatifloxacin 5 mg/mL | Solution/ dropsOphthalmic | 61314-672 | 61314-0672-25 | — |
| Meropenem | Meropenem 500 mg/20mL | InjectionIntravenous | 0781-3000 | 00781-3000-9500781-3000-96 | — |
| Meropenem | Meropenem 1 g/30mL | InjectionIntravenous | 0781-3098 | 00781-3098-9500781-3098-96 | — |
| Oxaliplatin | Oxaliplatin 5 mg/mL | Injection, SolutionIntravenous | 0781-9315 | 00781-9315-70 | — |
| Oxaliplatin | Oxaliplatin 5 mg/mL | Injection, SolutionIntravenous | 0781-9317 | 00781-9317-80 | — |
| Linezolid | Linezolid 200 mg/100mL | Injection, SolutionIntravenous | 0781-3431 | — | — |
| Linezolid | Linezolid 600 mg/300mL | Injection, SolutionIntravenous | 0781-3433 | 00781-3433-95 | — |
| Methylphenidate | Methylphenidate hydrochloride 10 mg/1 | Capsule, Extended releaseOral | 0781-2361 | — | — |
| Methylphenidate | Methylphenidate hydrochloride 20 mg/1 | Capsule, Extended releaseOral | 0781-2362 | 00781-2362-01 | — |
| Methylphenidate | Methylphenidate hydrochloride 30 mg/1 | Capsule, Extended releaseOral | 0781-2363 | 00781-2363-01 | — |
| Methylphenidate | Methylphenidate hydrochloride 40 mg/1 | Capsule, Extended releaseOral | 0781-2364 | — | — |
| Methylphenidate | Methylphenidate hydrochloride 10 mg/1 | Capsule, Extended releaseOral | 0781-2383 | 00781-2383-01 | — |
| Methylphenidate | Methylphenidate hydrochloride 20 mg/1 | Capsule, Extended releaseOral | 0781-2384 | 00781-2384-01 | — |
| Methylphenidate | Methylphenidate hydrochloride 30 mg/1 | Capsule, Extended releaseOral | 0781-2385 | 00781-2385-01 | — |
| Methylphenidate | Methylphenidate hydrochloride 40 mg/1 | Capsule, Extended releaseOral | 0781-2386 | 00781-2386-01 | — |
| Fluvastatin Sodium ERfluvastatin sodium | Fluvastatin sodium 80 mg/1 | Tablet, Extended releaseOral | 0781-8017 | 00781-8017-0100781-8017-31 | — |
| Rivastigmine | Rivastigmine 4.6 mg/24h | Patch, Extended releaseTransdermal | 0781-7304 | 00781-7304-31 | — |
| Rivastigmine | Rivastigmine 9.5 mg/24h | Patch, Extended releaseTransdermal | 0781-7309 | 00781-7309-31 | — |
| Rivastigmine | Rivastigmine 13.3 mg/24h | Patch, Extended releaseTransdermal | 0781-7313 | 00781-7313-31 | — |
| Estradiol Valerate and Estradiol Valerate/Dienogest | — | Kit | 0781-4110 | 00781-4110-15 | — |
| Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium | — | Kit | 0781-4103 | 00781-4103-15 | — |
| Glatopaglatiramer acetate | Glatiramer acetate 20 mg/mL | Injection, SolutionSubcutaneous | 0781-3234 | 00781-3234-34 | — |
| bivalirudin | Bivalirudin 250 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 0781-3158 | 00781-3158-95 | — |
| Benazepril Hydrochloride and Hydrochlorothiazide | Benazepril hydrochloride 5 mg/1; Hydrochlorothiazide 6.25 mg/1 | Tablet, Film coatedOral | 0185-0236 | 00185-0236-01 | — |
| Zarxiofilgrastim-sndz | Filgrastim 300 ug/.5mL | Injection, SolutionIntravenous, Subcutaneous | 61314-318 | 61314-0318-0161314-0318-1061314-0318-63+1 more | — |
| Zarxiofilgrastim-sndz | Filgrastim 480 ug/.8mL | Injection, SolutionIntravenous, Subcutaneous | 61314-326 | 61314-0326-0161314-0326-1061314-0326-63+1 more | — |
| Oxaliplatin | Oxaliplatin 5 mg/mL | Injection, SolutionIntravenous | 0781-3315 | 00781-3315-70 | — |
| Oxaliplatin | Oxaliplatin 5 mg/mL | Injection, SolutionIntravenous | 0781-3317 | 00781-3317-80 | — |
| Estradiol | Estradiol .0375 mg/d | Patch, Extended releaseTransdermal | 0781-7138 | 00781-7138-83 | — |
| Estradiol | Estradiol .05 mg/d | Patch, Extended releaseTransdermal | 0781-7144 | 00781-7144-83 | — |
| Estradiol | Estradiol .075 mg/d | Patch, Extended releaseTransdermal | 0781-7156 | 00781-7156-83 | — |
| Estradiol | Estradiol .1 mg/d | Patch, Extended releaseTransdermal | 0781-7167 | 00781-7167-83 | — |
| Estradiol | Estradiol .025 mg/d | Patch, Extended releaseTransdermal | 0781-7129 | 00781-7129-83 | — |
| Cyclophosphamide | Cyclophosphamide 2 g/100mL | Injection, Powder, For solutionIntravenous, Oral | 0781-3255 | 00781-3255-94 | — |
| Cyclophosphamide | Cyclophosphamide 500 mg/25mL | Injection, Powder, For solutionIntravenous, Oral | 0781-3233 | 00781-3233-94 | — |
| Cyclophosphamide | Cyclophosphamide 1 g/50mL | Injection, Powder, For solutionIntravenous, Oral | 0781-3244 | 00781-3244-94 | — |
| Piperacillin and Tazobactam | Piperacillin sodium 12 g/100mL; Tazobactam sodium 1.5 g/100mL | Injection, Powder, Lyophilized, For solutionIntravenous, Parenteral | 0781-3117 | — | — |
| Carbidopa, Levodopa, and Entacapone | Carbidopa 37.5 mg/1 + 2 more ingredients | Tablet, Film coatedOral | 0781-5654 | 00781-5654-01 | — |
| Carbidopa, Levodopa, and Entacapone | Carbidopa 18.75 mg/1 + 2 more ingredients | Tablet, Film coatedOral | 0781-5625 | 00781-5625-01 | — |
| Carbidopa, Levodopa, and Entacapone | Carbidopa 25 mg/1 + 2 more ingredients | Tablet, Film coatedOral | 0781-5637 | 00781-5637-01 | — |
| Carbidopa, Levodopa, and Entacapone | Carbidopa 31.25 mg/1 + 2 more ingredients | Tablet, Film coatedOral | 0781-5641 | 00781-5641-01 | — |
| Carbidopa, Levodopa, and Entacapone | Carbidopa 50 mg/1 + 2 more ingredients | Tablet, Film coatedOral | 0781-5669 | 00781-5669-01 | — |
| Carbidopa, Levodopa, and Entacapone | Carbidopa 12.5 mg/1 + 2 more ingredients | Tablet, Film coatedOral | 0781-5613 | 00781-5613-01 | — |
| Heparin Sodium | Heparin sodium 10000 [USP'U]/mL | Injection, SolutionIntravenous, Subcutaneous | 0781-3533 | 00781-3533-25 | — |
Sandoz Inc: common questions
- What is Sandoz Inc's NDC labeler code?
- 0781, 61314. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Sandoz Inc?
- Med-Code's HCPCS directory matches J0178, J1756, J0897, J0135, J3357, J2778 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.